Factorial validity and invariance of a survey measuring psychosocial correlates of colorectal cancer screening among African Americans and Caucasians

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 12, 2005, Pages 2855-2861

  Tiro, Jasmin A ^a   Vernon, Sally W ^b   Hyslop, Terry ^c   Myers, Ronald E ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER SCREENING; CAUCASIAN; COLORECTAL CANCER; CORRELATION ANALYSIS; FACTORIAL ANALYSIS; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MAXIMUM LIKELIHOOD METHOD; PRIORITY JOURNAL; RACE DIFFERENCE; RELIABILITY; SEX DIFFERENCE; SOCIAL PSYCHOLOGY; VALIDATION PROCESS;

AFRICAN AMERICANS; AGED; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 30344488461     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0217     Document Type: Article

References (66)

1. Hardcastle JD, Chamberlain JO, Robinson MHE, et al. Randomized controlled trial of fecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
2. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomized study of screening for colorectal cancer with fecal-occult-blood test. Lancet 1996;348:1467-71.
3. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365-71.
4. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992;84:1572-5.
5. Selby JV, Friedman GD, Quesenberry CP, Jr., Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-7.
6. Swan J, Breen NL, Coates RJ, Rimer BK, Lee NC. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer 2003;97:1528-40.
7. Seeff LC, Nadel MR, Klabunde C, et al. Patterns and predictors of colorectal cancer test use in the adult US population: results from the 2000 National Health Interview Survey. Cancer 2004;100:2093-103.
8. Sallis JF, Owen N, Fotheringham MJ. Behavioral epidemiology: a systematic framework to classify phases of research on health promotion and disease prevention. Ann Behav Med 2000;22:294-8.
9. Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst 1997;89:1406-22.
10. Peterson SK, Vernon SW. A review of patient and physician adherence to colorectal cancer screening guidelines. Semin Colon Rectal Surg 2000;11: 58-72.
11. Farrands PA, Hardcastle JD, Chamberlain JO, Moss SM. Factors affecting compliance with screening for colorectal cancer. Commun Med 1984;6:12-9.
12. Kremers SPJ, Mesters I, Pladdet IE, Van den Borne B, Stockbrugger RW. Participation in a sigmoidoscopic colorectal cancer screening program: a pilot study. Cancer Epidemiol Biomarkers Prev 2000;9:1127-30.
13. Lewis SF, Jensen NM. Screening sigmoidoscopy: factors associated with utilization. J Gen Intern Med 1996;11:542-4.
14. Codori A-M, Petersen GM, Miglioretti DL, Boyd PA. Health beliefs and endoscopic screening for colorectal cancer: potential for cancer prevention. Prev Med 2001;33:128-36.
15. Janz NK, Wren PA, Schottenfeld D, Guire KE. Colorectal cancer screening attitudes and behavior: a population-based study. Prev Med 2003;37:627-34.
16. Paskett ED, Rushing J, D'Agostino RB, Tatum CM. Cancer screening behaviors of low-income women: the impact of race. Women's Health 1997;3:203-26.
17. Brawarsky P, Brooks DR, Mucci LA. Correlates of colorectal cancer testing in Massachusetts men and women. Prev Med 2003;36:659-68.
18. Madlensky L, Esplen MJ, Gallinger S, McLaughlin J, Goel V. Relatives of colorectal cancer patients. Am J Prev Med 2003;25:187-94.
19. Sun WY, Basch CE, Wolf RL, Li XJ. Factors associated with colorectal cancer screening among Chinese-Americans. Prev Med 2004;39:323-9.
20. Price JH. Perceptions of colorectal cancer in a socioeconomically disadvantaged population. J Commun Health 1993;18:347-62.
21. Halper MS, Winawer SJ, Brody RS, Andrews M, Roth D, Burton G. Issues of patient compliance. In: Winawer SJ, Schottenfeld D, editors. Colorectal cancer: prevention, epidemiology, and screening. New York (NY): Raven Press; 1980. p. 299-310.
22. Friedman LC, Webb JA, Richards CS, Plon SE. Psychological and behavioral factors associated with colorectal cancer screening among Ashkenazim. Prev Med 1999;29:119-25.
23. Sandler RS, DeVellis BM, Blalock SJ, Holland KL. Participation of high-risk subjects in colon cancer screening. Cancer 1989;63:2211-5.
24. Kelly RB, Shank JC. Adherence to screening flexible sigmoidoscopy in asymptomatic patients. Med Care 1992;30:1029-42.
25. Brenes GA, Paskett ED. Predictors of stage of adoption for colorectal cancer screening. Prev Med 2000;31:410-6.
26. Vernon SW, Myers RE, Tilley BC. Development and validation of an instrument to measure factors related to colorectal cancer screening adherence. Cancer Epidemiol Biomarkers Prev 1997;6:825-32.
27. Rawl SR, Champion VL, Menon U, Skinner CS. Validation of scales to measure benefits and barriers to colorectal cancer screening: scale development. J Psychosoc Oncol 2001;19:47-63.
28. Widaman KF, Reise SP. Exploring the measurement invariance of psychological instruments: applications in the substance use domain. In: Bryant KJ, Windle M, West SG, editors. The science of prevention: methodologic advances from alcohol and substance abuse research. 1st ed. Washington (District of Columbia): American Psychological Association; 1997. p. 281-324.
29. Vernon SW, Briss PA, Tiro JA, Warnecke RB. Some methodologic lessons learned from cancer screening research. Cancer 2004;101:1131-45.
30. Johnson TP, O'Rourke D, Chavez N, et al. Cultural variations in the interpretation of health survey questions. In: Warnecke RB, editor. Health survey research methods conference proceedings. DHHS Publication No. (PHS) 96-1013. Hyattsville (Maryland): National Center for Health Statistics; 1996. p. 57-62.
31. Pasick RJ, Stewart S, Bird JA, D'Onofrio CN. Quality of data in multiethnic health surveys. Public Health Rep 2001;116:223-43.
32. Champion VL, Menon U, McQuillen DH, Scott C. Validity of self-reported mammography in low-income African-American women. Am J Prev Med 1998;14:111-7.
33. Champion VL, Scott CR. Reliability and validity of breast cancer screening belief scales in African American women. Nurs Res 1997;46:331-7.
34. Myers R, Wolf T. Instrument development for a colorectal cancer screening survey. Philadelphia (Pennsylvania): Fox Chase Cancer Center; 1990. p. 231-2.
35. Myers RE, Ross E, Jepson C, et al. Modeling adherence to colorectal cancer screening. Prev Med 1994;23:142-51.
36. Watts BG, Vernon SW, Myers R, Tilley BC. Intention to be screened over time for colorectal cancer in male automotive workers. Cancer Epidemiol Biomarkers Prev 2003;12:339-49.
37. Rosenstock IM. The Health Belief Model and preventive health behavior. Health Educ Q 1974;2:354-86.
38. Sheeran P, Abraham C. The health belief model. In: Conner M, Norman P, editors. Predicting health behavior. 1st ed. Philadelphia (Pennsylvania): Open University Press; 1995. p. 23-61.
39. Bandura A. Social foundations of thought and action: a social cognitive theory. Englewood Cliffs (New Jersey): Prentice Hall; 1986.
40. Bandura A. Health promotion from the perspective of social cognitive theory. In: Norman P, Abraham C, Conner M, editors. Understanding and changing health behaviour: from health beliefs to self-regulation. Amsterdam (the Netherlands): Harwood Academic Publishers; 2000. p. 299-339.
41. Ajzen I, Fishbein M. Understanding attitudes and predicting social behavior. Englewood Cliffs (NJ): Prentice-Hall, Inc.; 1980.
42. Fishbein M, Ajzen I. Belief, attitude, intention and behavior: an introduction to theory and research. Reading (Massachusetts): Addison-Wesley; 1975.
43. Antonovsky A. The sense of coherence as a determinant of health. In Behavioral health: a handbook of health enhancement and disease prevention. New York: John Wiley & Sons; 1984.
44. Antonovsky A. Health stress and coping. San Francisco (California): Jossey-Bass; 1979.
45. Rogers RW. A protection motivation theory of fear appeals and attitude change. J Psychol 1975;91:93-114.
46. Myers RE, Track BJ, Lerman CL, et al. Adherence to colorectal cancer screening in an HMO population. Prev Med 1990;19:502-14.
47. Menon U, Champion VL, Larkin GN, et al. Beliefs associated with fecal occult blood test and colonoscopy use at a work-site colon cancer screening program. J Occup Environ Med 2003;45:891-8.
48. Herbert C, Launoy G, Gignoux M. Factors affecting compliance with colorectal cancer screening in France: differences between intention to participate and actual participation. Eur J Cancer Prev 1997;6:44-52.
49. Tang TS, Solomon LJ, McCracken LM. Barriers to fecal occult blood testing and sigmoidoscopy among older Chinese-American women. Cancer Pract 2001;9:277-82.
50. Taylor V, Lessler D, Mertens K, et al. Colorectal cancer screening among African Americans: the importance of physician recommendation. J Natl Med Assoc 2003;95:806-12.
51. Honda K. Factors associated with colorectal cancer screening among the U.S. urban Japanese population. Am J Public Health 2004;94:815-22.
52. Zapka JG, Puleo E, Vickers-Lahti M, Luckmann R. Healthcare system factors and colorectal cancer screening. Am J Prev Med 2002;23:28-35.
53. Manne S, Markowitz A, Winawer SJ, et al. Correlates of colorectal cancer screening compliance and stage of adoption among siblings of individuals with early onset colorectal cancer. Health Psychol 2002;21: 3-15.
54. Greiner KA, Engelman KK, Hall MA, Ellerbeck EF. Barriers to colorectal cancer screening in rural primary care. Prev Med 2004;38:269-75.
55. Ajzen I. From intentions to action: a theory of planned behavior. In: Kuhl J, Beckman JC, editors. Action control: from cognitions to behaviors. New York: Springer; 1985. p. 11-39.
56. Cialdini RB, Trost MB. Social influence: social norms conformity, and compliance. In: Gilbert DT, Fiske ST, Lindzey G, editors. Handbook of social psychology. 4th ed. Boston: McGraw-Hill; 1999. p. 151-92.
57. Bentler PM. EQS for Windows (version 6.1) [computer software]. Encino (California): Multivariate Software; 2004.
58. Hu LH, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equation Model 1999;6:1-55.
59. Bollen KA. Structural equations with latent variables. New York: Wiley; 1989.
60. Byrne BM, Baron P. The Beck depression inventory: testing and cross-validating a hierarchical factor structure for nonclinical adolescents. Meas Eval Couns Dev 1993;26:164-78.
61. Satorra A, Bentler PM. Corrections to test statistics and standard errors in covariance structure analysis. In: Von Eye A, Clogg CC, editors. Latent variable analysis: applications for developmental research. Thousand Oaks (California): Sage; 1994. p. 399-519.
62. Marsh HM, Balla JR, McDonald RP. Goodness-of-fit indexes in confirmatory factor analysis: the effect of sample size. Psychol Bull 1988;103:391-410.
63. Cortina JM. What is coefficient α? An examination of theory and applications. J Appl Psychol 1993;78:98-104.
64. Boomsma A. Nonconvergence, improper solutions, and starting values in LISREL maximum likelihood estimation. Psychometrika 1985;50:229-42.
65. Anderson JC, Gerbing DW. The effect of sampling error on convergence, improper solutions, and goodness-of-fit indices for maximum likelihood confirmatory factor analysis. Psychometrika 1984;49:155-73.
66. 2 test statistic for moment structure analysis. Psychometrika 2001;66:507-14.